10MG
Buy 3+ for $46.55 each and save 5%
Buy 5+ for $44.10 each and save 10%
Buy 10+ for $41.65 each and save 15%
This product is for research purposes only. Not for human consumption.
Purity: >98% (HPLC verified)
Formulation: Lyophilized powder
Molecular Formula: C41H70N16O16S
Molecular Weight: 1075.16 g/mol
CAS Number: 868844-74-0
PubChem CID: N/A
Snap-8
Overview
Acetyl Octapeptide-3 (sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2) is a synthetic peptide that is an analog of Acetyl Hexapeptide-8. It was designed based on the structure of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex, a key protein assembly in neurotransmitter release.
The peptide's design rationale relates to its potential interaction with the SNARE complex at the neuromuscular junction. It is studied for its effects on modulating neurotransmitter release and the intensity of muscle cell contraction in experimental models.
Mechanism of Action
Acetyl Octapeptide-3 is investigated for its activity related to the SNARE complex, which is essential for the fusion of synaptic vesicles with the presynaptic membrane and subsequent neurotransmitter release.
SNARE Complex Function
The SNARE complex is formed by the interaction of three proteins: SNAP-25 (synaptosome-associated protein of 25 kDa), syntaxin-1, and VAMP (vesicle-associated membrane protein). Formation of this complex is a critical step that brings the vesicle and plasma membranes together, facilitating the release of neurotransmitters like acetylcholine into the synaptic cleft, which in turn can trigger muscle cell contraction.
Proposed Mechanism of Action
Acetyl Octapeptide-3 is proposed to act as a competitive inhibitor of the SNARE complex. It is structurally similar to the N-terminal end of the SNAP-25 protein and is thought to compete with native SNAP-25 for a position in the SNARE complex. By interfering with the proper formation of the complex, the peptide may destabilize it, thereby reducing the efficiency of neurotransmitter release in a concentration-dependent manner in some experimental systems.
This mechanism differs from that of botulinum neurotoxins, which function by proteolytically cleaving specific SNARE proteins. The interaction of Acetyl Octapeptide-3 is not reported to involve protein cleavage.
Research Findings
Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.
Research Applications
- SNARE complex competitive inhibition studies
- Neurotransmitter release assays
- Neuromuscular junction research
- Peptide structure-activity relationship studies
- In vitro muscle cell contraction models
- Peptide permeation and delivery research
Laboratory Handling & Limitations
This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.
Laboratory Handling
Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.
Research Limitations
Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.
Scientific References
Research Use Only
This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.